Compare, Analyse Torrent Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ACTAVIS (US) - Comparison Results

TORRENT PHARMA     Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ACTAVIS
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-19
ACTAVIS
Dec-18
TORRENT PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,96414,247-   
Low Rs1,2459,557-   
Sales per share (Unadj.) Rs453.43,494.9-  
Earnings per share (Unadj.) Rs25.8-1,125.7-  
Cash flow per share (Unadj.) Rs62.3368.3-  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs279.214,414.7-  
Shares outstanding (eoy) m169.22332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.53.4 103.9%   
Avg P/E ratio x62.2-10.6 -588.6%  
P/CF ratio (eoy) x25.832.3 79.7%  
Price / Book Value ratio x5.70.8 696.0%  
Dividend payout %65.90-   
Avg Mkt Cap Rs m271,5133,958,701 6.9%   
No. of employees `00013.616.9 80.5%   
Total wages/salary Rs m14,0380-   
Avg. sales/employee Rs Th5,642.668,780.9 8.2%   
Avg. wages/employee Rs Th1,032.40-   
Avg. net profit/employee Rs Th320.9-22,154.4 -1.4%   
INCOME DATA
Net Sales Rs m76,7281,162,397 6.6%  
Other income Rs m57122,229 2.6%   
Total revenues Rs m77,2991,184,626 6.5%   
Gross profit Rs m19,83130,461 65.1%  
Depreciation Rs m6,177496,899 1.2%   
Interest Rs m5,03867,077 7.5%   
Profit before tax Rs m9,187-511,287 -1.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,570130,399 -2.7%   
Tax Rs m1,254-6,479 -19.3%   
Profit after tax Rs m4,363-374,409 -1.2%  
Gross profit margin %25.82.6 986.3%  
Effective tax rate %13.61.3 1,076.7%   
Net profit margin %5.7-32.2 -17.7%  
BALANCE SHEET DATA
Current assets Rs m50,375476,754 10.6%   
Current liabilities Rs m51,653421,753 12.2%   
Net working cap to sales %-1.74.7 -35.2%  
Current ratio x1.01.1 86.3%  
Inventory Days Days9220 470.1%  
Debtors Days Days6866 103.0%  
Net fixed assets Rs m83,648131,577 63.6%   
Share capital Rs m8460-   
"Free" reserves Rs m46,3970-   
Net worth Rs m47,2444,794,344 1.0%   
Long term debt Rs m39,1291,688,262 2.3%   
Total assets Rs m141,2097,494,650 1.9%  
Interest coverage x2.8-6.6 -42.6%   
Debt to equity ratio x0.80.4 235.2%  
Sales to assets ratio x0.50.2 350.3%   
Return on assets %6.7-4.1 -162.3%  
Return on equity %9.2-7.8 -118.3%  
Return on capital %12.3-4.8 -254.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m16,5810-   
CASH FLOW
From Operations Rs m17,981415,281 4.3%  
From Investments Rs m-2,413228,143 -1.1%  
From Financial Activity Rs m-13,145-712,746 1.8%  
Net Cashflow Rs m2,380-68,977 -3.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.63 Rs / USD

Compare TORRENT PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: FRESENIUS KABI ONCO.  DR. DATSONS LABS  SUVEN LIFE SCIENCES  AUROBINDO PHARMA  FULFORD INDIA  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

FREE Event: Discover Your First Stock for a Potential Rs 7 Crore in Long-term Wealth
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

TORRENT PHARMA SHARE PRICE


May 7, 2021 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS